Officials from HHS are currently talking with pharmaceutical companies to pursue voluntary price cuts as part of President Donald Trump’s drug pricing plan, The Hill reports.

Five months before the 2018 midterm elections, California Republicans see their opponents’ embrace of exploring single-payer healthcare as an opportunity.

On Monday, June 11, CMS released guidance for states to leverage Medicaid in fighting opioid abuse and misuse—with the document making specific mention of efforts to reduce negative impact in infants and outlining potential benefits of health information technology.

Private equity firm KKR & Co. announced its plan to buy Envision Healthcare for $5.57 billion and debt. The all-cash transaction will value Envision at $9.9 billion, according to Bloomberg.

Stryker approached Boston Scientific with a takeover bid on Monday, June 11, according to the Wall Street Journal.

Nancy Pelosi didn’t endorse any single-payer proposals as other Democrats have in the Senate, though she did reiterate her support for a government-run insurance option.

The World Molecular Imaging Society, American College of Radiology, Society of Nuclear Medicine and Molecular Imaging and members of the National Oncologic PET Registry (NOPR) Working Group issued a statement Friday, June 8, urging CMS to reconsider its decision to decline coverage for PET imaging with sodium fluoride (NaF) for Medicare patients with metastatic cancer.

Attorney General Sessions doesn’t go as far as arguing the entire law would be invalid, but the provisions he deemed “inseverable” from the mandate include some of the ACA’s key protections, like not allowing insurers to charge more or deny coverage based on a consumer’s pre-existing conditions.